These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4279526)

  • 41. Comparative studies of the effect of fibrinolytic inhibitors (synthetic and naturally occurring substances) on coagulation and fibrinolytic systems in vitro and in vivo, and their clinical applications.
    Matsuoka M; Sakuragawa N; Yoneyama Y
    Acta Med Biol (Niigata); 1969 Mar; 16(3):105-20. PubMed ID: 4239124
    [No Abstract]   [Full Text] [Related]  

  • 42. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 43. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease.
    Wiman B; Hamsten A
    Semin Thromb Hemost; 1990 Jul; 16(3):207-16. PubMed ID: 2146744
    [No Abstract]   [Full Text] [Related]  

  • 44. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On the anticoagulant effect of some inhibitors of fibrinolysis].
    Donner L; Housková J
    Sb Lek; 1969 Apr; 71(4):85-91. PubMed ID: 5305357
    [No Abstract]   [Full Text] [Related]  

  • 46. [New hypothesis on fibrinolysis and coagulation mechanisms. Application in several experimental facts].
    Daver J; Desnoyers P
    Anesth Analg (Paris); 1974; 31(4):539-49. PubMed ID: 4440895
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of dextran on fibrinolysis inhibition activity in serum.
    Carlin G; Saldeen T
    Thromb Res; 1978 Jun; 12(6):1165-75. PubMed ID: 151346
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy.
    Stehling F; Weber R; Ozcelik A; Bröcker M; Volbracht L; Diener HC; Busch E
    Neurosci Lett; 2008 Aug; 441(1):39-43. PubMed ID: 18597942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 50. [Basic principles of thrombolytic therapy].
    van de Loo J
    Internist (Berl); 1969 Jan; 10(1):16-21. PubMed ID: 4190309
    [No Abstract]   [Full Text] [Related]  

  • 51. [The antifibrinolytic activity of the blood in patients with cardiovascular pathologies under the effect of anticoagulant therapy].
    Urbaniuk KG; Andreenko GV; Mizin II
    Vrach Delo; 1967 Aug; 8():24-6. PubMed ID: 5612693
    [No Abstract]   [Full Text] [Related]  

  • 52. [Blood coagulation and fibrinolysis in wound healing].
    Sedlarik K
    Z Arztl Fortbild (Jena); 1977 Aug; 71(15):722-5. PubMed ID: 335677
    [No Abstract]   [Full Text] [Related]  

  • 53. Current concepts of the relationship of thrombosis and thrombolysis.
    Sherry S
    Res Publ Assoc Res Nerv Ment Dis; 1966; 41():349-58. PubMed ID: 4224933
    [No Abstract]   [Full Text] [Related]  

  • 54. [Characteristics of components of the fibrinolytic system in healthy children].
    Sofronova LV
    Vopr Okhr Materin Det; 1975 Jun; 20(6):17-9. PubMed ID: 124506
    [No Abstract]   [Full Text] [Related]  

  • 55. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 56. From Cerius² based stereoview to mouse and enzyme: the model systems for discovery of novel urokinase inhibitors.
    Mei S; Liu J; Zhao M; Wang W; Wang Y; Wu G; Zheng M; Peng S
    Mol Biosyst; 2011 Sep; 7(9):2664-9. PubMed ID: 21731957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombin, a link between coagulation activation and fibrinolysis.
    Bertina RM; van Tilburg NH; de Fouw NJ; Haverkate F
    Ann N Y Acad Sci; 1992 Dec; 667():239-48. PubMed ID: 1309042
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 59. Influence of ethanol and acetaldehyde on fibrinolytic system (examinations in vitro).
    Skrzydlewska E; Worowski K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():163-73. PubMed ID: 6242841
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of three mamba venoms on the haemostatic mechanism.
    MacKay N; Ferguson JC; McNicol GP
    Br J Haematol; 1968 Dec; 15(6):549-59. PubMed ID: 4237091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.